Lyra Therapeutics News and Activities

Lyra Therapeutics is a company listed under the stock ticker LYRA (US).

View the org chart displaying its 13 main executives

Most searched biographies at Lyra Therapeutics

• Maria Palasis, Director, President and Chief Executive Officer
• Bradford Smith, Director
• Nancy Snyderman, Director

Popular executive movements at Lyra Therapeutics

• Mary Roane, Senior Director, Technical Operations, has left the company  (posted on February 26 2026).

Create your alert
to follow the executive moves at Lyra Therapeutics.

Lyra Therapeutics has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Lyra Therapeutics

• Lyra Therapeutics Presents Clinical Data Demonstrating LYR-210’s Local Anti Inflammatory Effects for the Treatment of Chronic Rhinosinusitis | Lyra Therapeutics, Inc.
• Lyra Therapeutics to Present Data Supporting LYR-210 for the Treatment of Chronic Rhinosinusitis | Lyra Therapeutics, Inc.

Social media about Lyra Therapeutics

• Lyra Therapeutics on Wikipedia, Google News & Yahoo Finance
• Lyra Therapeutics on LinkedIn, X (Twitter) & YouTube